FKBP5 as a selection biomarker for gemcitabine and AKT inhibitors in treatment of pancreatic cancer

Junmei Hou, Liewei Wang

Research output: Contribution to journalArticlepeer-review

32 Scopus citations

Fingerprint Dive into the research topics of 'FKBP5 as a selection biomarker for gemcitabine and AKT inhibitors in treatment of pancreatic cancer'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences

Agriculture & Biology